QURE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
QURE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
uniQure NV has the GF Value Rank of 1.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Biotechnology subindustry, uniQure NV's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, uniQure NV's GF Value Rank distribution charts can be found below:
* The bar in red indicates where uniQure NV's GF Value Rank falls into.
Thank you for viewing the detailed overview of uniQure NV's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Walid Abi-saab | officer: Chief Medical Officer | C/O UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM P7 11058BP |
Ricardo Dolmetsch | officer: President, R&D | 113 HARTWELL AVENUE, LEXINGTON MA 02421 |
Pierre Caloz | officer: Chief Operating Officer | UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM P7 P7 11058BP |
Madhavan Balachandran | director | C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
Rachelle Suzanne Jacques | director | C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 100 RIVER RIDGE DRIVE, NORWOOD MA 02062 |
Robert Gut | director | C/O VERSARTIS, INC., 4200 BOHANNON DRIVE, SUITE 250, MENLO PARK CA 94025 |
Leonard E Post | director | |
Christian Klemt | officer: Chief Financial Officer | PAASHEUVELWEG 25A, AMSTERDAM P7 1105 BP |
Jack Kaye | director | C/O KERYX BIOPHARMACEUTICALS, 750 LEXINGTON AVENUE, NEW YORK X1 10022 |
Jeremy P. Springhorn | director | C/O UNIQUIRE N.V., 113 HARTWELL AVENUE, LEXINGTON MA 02421 |
David D. Meek | director | 3000 KENT AVENUE; SUITE A1-100, WEST LAFAYETTE IN 47906 |
Paula Soteropoulos | director | 49 WINONA STREET, PEABODY MA 01960 |
Jeannette Potts | officer: See Remarks | C/O FORMA THERAPEUTICS HOLDINGS, INC., 500 ARSENAL STREET, SUITE 100, WATERTOWN MA 02472 |
Matthew C Kapusta | director, officer: CEO, Managing Director | 7358 MCVAY ROAD, GERMANTOWN TN 38138 |
Kuta Alexander Edward Iii | officer: Executive VP, Operations | 239 WILLIS ROAD, SUDBURY MA 01776 |
From GuruFocus
By Value_Insider Value_Insider • 11-29-2022
By PurpleRose PurpleRose • 07-13-2022
By Marketwired • 06-21-2023
By sperokesalga sperokesalga • 06-16-2023
By Stock market mentor Stock market mentor • 01-31-2023
By Marketwired • 10-05-2023
By Value_Insider Value_Insider • 12-20-2022
By sperokesalga sperokesalga • 02-23-2023
By Value_Insider Value_Insider • 12-16-2022
By GuruFocus Research • 11-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.